Outcomes of difluprednate treatment for corneal graft rejection.

MLA

Sorkin, Nir, et al. “Outcomes of Difluprednate Treatment for Corneal Graft Rejection.” Canadian Journal of Ophthalmology. Journal Canadien d’ophtalmologie, vol. 55, no. 1, Feb. 2020, pp. 82–86. EBSCOhost, https://doi.org/10.1016/j.jcjo.2019.07.010.

APA

Sorkin, N., Yang, Y., Mednick, Z., Einan-Lifshitz, A., Trinh, T., Santaella, G., Telli, A., Chan, C. C., Slomovic, A. R., & Rootman, D. S. (2020). Outcomes of difluprednate treatment for corneal graft rejection. Canadian Journal of Ophthalmology. Journal Canadien d’ophtalmologie, 55(1), 82–86. https://doi.org/10.1016/j.jcjo.2019.07.010

Chicago

Sorkin, Nir, Yelin Yang, Zale Mednick, Adi Einan-Lifshitz, Tanya Trinh, Gisella Santaella, Alexandre Telli, Clara C Chan, Allan R Slomovic, and David S Rootman. 2020. “Outcomes of Difluprednate Treatment for Corneal Graft Rejection.” Canadian Journal of Ophthalmology. Journal Canadien d’ophtalmologie 55 (1): 82–86. doi:10.1016/j.jcjo.2019.07.010.